Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Non-cash Items (2020 - 2025)

BioAtla (BCAB) has disclosed Non-cash Items for 6 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • For Q4 2025, Non-cash Items changed N/A year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
  • Non-cash Items hit $2.2 million in Q4 2025 for BioAtla, down from $2.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.6 billion in Q4 2022 and bottomed at $7747.0 in Q3 2021.
  • Average Non-cash Items over 5 years is $251.6 million, with a median of $2.8 million recorded in 2025.
  • Year-over-year, Non-cash Items surged 9967.98% in 2021 and then plummeted 98.97% in 2022.
  • BioAtla's Non-cash Items stood at $991.5 million in 2021, then skyrocketed by 266.73% to $3.6 billion in 2022, then plummeted by 97.95% to $74.7 million in 2023, then plummeted by 95.58% to $3.3 million in 2024, then tumbled by 33.33% to $2.2 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $2.2 million, $2.5 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.